Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Association between preoperative levels of 25-hydroxyvitamin D and hospital-acquired infections after hepatobiliary surgery: A prospective study in a third-level hospital.

Laviano E, Sanchez Rubio M, González-Nicolás MT, Palacian MP, López J, Gilaberte Y, Calmarza P, Rezusta A, Serrablo A.

PLoS One. 2020 Mar 26;15(3):e0230336. doi: 10.1371/journal.pone.0230336. eCollection 2020.

2.

Genetic contribution to lipid target achievement with statin therapy: a prospective study.

Ruiz-Iruela C, Candás-Estébanez B, Pintó-Sala X, Baena-Díez N, Caixàs-Pedragós A, Güell-Miró R, Navarro-Badal R, Calmarza P, Puzo-Foncilla JL, Alía-Ramos P, Padró-Miquel A.

Pharmacogenomics J. 2019 Dec 6. doi: 10.1038/s41397-019-0136-7. [Epub ahead of print]

PMID:
31806882
3.

Standards for global cardiovascular risk management arteriosclerosis.

Mostaza JM, Pintó X, Armario P, Masana L, Ascaso JF, Valdivielso P; en nombre de la Sociedad Española de Arteriosclerosis; Miembros de la Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2019 Jul;31 Suppl 1:1-43. doi: 10.1016/j.arteri.2019.03.004. Epub 2019 Apr 11. English, Spanish.

4.

KCa3.1 Transgene Induction in Murine Intestinal Epithelium Causes Duodenal Chyme Accumulation and Impairs Duodenal Contractility.

Valero MS, Ramón-Gimenez M, Lozano-Gerona J, Delgado-Wicke P, Calmarza P, Oliván-Viguera A, López V, Garcia-Otín ÁL, Valero S, Pueyo E, Hamilton KL, Miura H, Köhler R.

Int J Mol Sci. 2019 Mar 8;20(5). pii: E1193. doi: 10.3390/ijms20051193.

5.

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.

Ruiz-Iruela C, Padró-Miquel A, Pintó-Sala X, Baena-Díez N, Caixàs-Pedragós A, Güell-Miró R, Navarro-Badal R, Jusmet-Miguel X, Calmarza P, Puzo-Foncilla JL, Alía-Ramos P, Candás-Estébanez B.

PLoS One. 2018 Oct 10;13(10):e0205430. doi: 10.1371/journal.pone.0205430. eCollection 2018.

6.

[Vitamin D levels in patients with recent cancer diagnosis].

Calmarza P, Sanz París A, Prieto López C, Llorente Barrio M, Boj Carceller D.

Nutr Hosp. 2018 Apr 5;35(4):903-908. doi: 10.20960/nh.1675. Spanish.

7.

Deficiencia de vitamina D en niños aragoneses sanos.

Martínez Redondo I, García Romero R, Calmarza P, De Arriba Muñoz A, Rodríguez Martínez G, Labarta Aizpún JI.

Nutr Hosp. 2018 Apr 27;35(4):782-788. doi: 10.20960/nh.1592. Spanish.

8.

Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.

Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F.

J Clin Lipidol. 2018 Sep - Oct;12(5):1190-1198. doi: 10.1016/j.jacl.2018.06.017. Epub 2018 Jul 4.

PMID:
30049591
9.

Removing Lipemia in Serum/Plasma Samples: A Multicenter Study.

Castro-Castro MJ, Candás-Estébanez B, Esteban-Salán M, Calmarza P, Arrobas-Velilla T, Romero-Román C, Pocoví-Mieras M, Aguilar-Doreste JÁ; Commission on Lipoprotein and Vascular Diseases, Sociedad Española de Química Clínica.

Ann Lab Med. 2018 Nov;38(6):518-523. doi: 10.3343/alm.2018.38.6.518.

10.

Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.

Calmarza P, Lapresta C, Martínez M, Lahoz R, Povar J.

Arch Cardiol Mex. 2018 Dec;88(5):391-396. doi: 10.1016/j.acmx.2017.11.003. Epub 2017 Dec 7.

PMID:
29233491
11.

[Usefulness of copeptin in the diagnosis of acute coronary syndrome in the emergency department of a tertiary hospital].

Calmarza P, Lapresta C, García-Castañón S, López-Perales C, Pérez-Guerrero A, Portolés A.

Clin Investig Arterioscler. 2016 Sep - Oct;28(5):209-215. doi: 10.1016/j.arteri.2016.07.001. Epub 2016 Sep 17. Spanish.

PMID:
27650658
12.

The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity.

Torres-Perez E, Valero M, Garcia-Rodriguez B, Gonzalez-Irazabal Y, Calmarza P, Calvo-Ruata L, Ortega C, Garcia-Sobreviela MP, Sanz-Paris A, Artigas JM, Lagos J, Arbones-Mainar JM.

Cardiovasc Diabetol. 2015 Apr 22;14:40. doi: 10.1186/s12933-015-0203-6.

13.

[Intima-media thickness in a middle-old age sample of the Spanish general population].

Calmarza P, Trejo JM, Lapresta C, López P.

Clin Investig Arterioscler. 2015 May-Jun;27(3):111-7. doi: 10.1016/j.arteri.2014.09.005. Epub 2014 Dec 23. Spanish.

PMID:
25542632
14.

Atherosclerosis progression in patients with autosomal dominant hypercholesterolemia in clinical practice.

Jarauta E, Mateo-Gallego R, Bea AM, Crespo M, Ballester A, Rubio MV, Baila-Rueda L, Calmarza P, Cenarro A, de Groot E, Civeira F.

J Clin Lipidol. 2014 Jul-Aug;8(4):373-80. doi: 10.1016/j.jacl.2014.06.002. Epub 2014 Jun 11.

PMID:
25110218
15.

[Effect of biliary obstruction on lipoprotein(a) concentration].

Calmarza P, Bajador E, Lapresta C, García Castañón S, de Castro I, Civeira F.

Clin Investig Arterioscler. 2014 Sep-Oct;26(5):218-23. doi: 10.1016/j.arteri.2014.01.003. Epub 2014 Mar 13. Spanish.

PMID:
24629889
16.

[Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].

Bea AM, Mateo-Gallego R, Jarauta E, Villa-Pobo R, Calmarza P, Lamiquiz-Moneo I, Cenarro A, Civeira F.

Clin Investig Arterioscler. 2014 Jul-Aug;26(4):176-83. doi: 10.1016/j.arteri.2014.01.001. Epub 2014 Feb 25. Spanish.

PMID:
24576773
17.

Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.

Cenarro A, Puzo J, Ferrando J, Mateo-Gallego R, Bea AM, Calmarza P, Jarauta E, Civeira F.

Metabolism. 2014 Mar;63(3):365-71. doi: 10.1016/j.metabol.2013.10.014. Epub 2013 Nov 6.

PMID:
24333007
18.

Using high-sensitivity troponin T: the importance of the proper gold standard.

Santaló M, Martin A, Velilla J, Povar J, Temboury F, Balaguer J, Muñoz M, Calmarza P, Ortiz C, Carratalá A, Gich I, Mercé J, Jaffe AS, Ordoñez-Llanos J.

Am J Med. 2013 Aug;126(8):709-17. doi: 10.1016/j.amjmed.2013.03.003. Epub 2013 Jun 10.

PMID:
23764266
19.

LDL oxidation and its association with carotid artery intima-media thickness and other cardiovascular risk factors in a sample of Spanish general population.

Calmarza P, Trejo JM, Lapresta C, López P.

Angiology. 2014 Apr;65(4):357-62. doi: 10.1177/0003319713488639. Epub 2013 May 9.

PMID:
23661771
20.

Lack of association between carotid intima-media thickness and apolipoprotein (a) isoforms in a sample of Spanish general population.

Calmarza P, Trejo JM, Lapresta C, Lopez P.

J Cardiol. 2013 May;61(5):372-7. doi: 10.1016/j.jjcc.2013.01.006. Epub 2013 Mar 6.

Supplemental Content

Loading ...
Support Center